Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE, Cohen AL, Colman H, Jensen RL, Fults DW, Couldwell WT. Huang LE, et al. Among authors: cohen al. Oncotarget. 2017 Jan 3;8(1):191-202. doi: 10.18632/oncotarget.13329. Oncotarget. 2017. PMID: 27852048 Free PMC article.
A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
Werner TL, Ray A, Lamb JG, VanBrocklin M, Hueftle K, Cohen AL, Beck AC, Buys SS, Dyess DL, Butler TW, Dumlao TL, Neumayer L, Khong HT. Werner TL, et al. Among authors: cohen al. Clin Breast Cancer. 2017 Nov;17(7):503-509. doi: 10.1016/j.clbc.2017.04.010. Epub 2017 Apr 29. Clin Breast Cancer. 2017. PMID: 28579139 Clinical Trial.
Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis.
Gardner LJ, Ward M, Andtbacka RHI, Boucher KM, Bowen GM, Bowles TL, Cohen AL, Grossmann K, Hitchcock YJ, Holmen SL, Hyngstrom J, Khong H, McMahon M, Monroe MM, Ross CB, Suneja G, Wada D, Grossman D. Gardner LJ, et al. Among authors: cohen al. Melanoma Res. 2017 Oct;27(5):477-484. doi: 10.1097/CMR.0000000000000382. Melanoma Res. 2017. PMID: 28800031 Free PMC article.
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer.
Koca E, Niravath PA, Ensor J, Patel TA, Li X, Hemati P, Wong H, Qian W, Boone T, Zhao J, Ramshesh PV, Cohen AL, Murthy A, Nair S, Darcourt JG, Belcheva A, Kaklamani VG, Chang JCN. Koca E, et al. Among authors: cohen al. Breast Cancer Res Treat. 2021 Jul;188(2):433-439. doi: 10.1007/s10549-021-06214-7. Epub 2021 Apr 15. Breast Cancer Res Treat. 2021. PMID: 33860388 Clinical Trial.
POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen.
Cohen AL, Factor RE, Mooney K, Salama ME, Wade M, Serpico V, Ostrander E, Nelson E, Porretta J, Matsen C, Bernard P, Boucher K, Neumayer L. Cohen AL, et al. Breast. 2017 Feb;31:219-223. doi: 10.1016/j.breast.2016.11.016. Epub 2016 Dec 6. Breast. 2017. PMID: 27915204 Clinical Trial.
434 results